Biomimetic Delivery Strategies at the Urothelium: Targeted Cytoinvasion in Bladder Cancer Cells via Lectin Bioconjugates

Lectin bioconjugates trigger urothelial cytoinvasion – A glycotargeted approach for improved intravesical drug delivery

(2012) L. Neutsch et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Potential Years of Life Lost Due to Urogenital Cancer in the United States: Trends From 1972 to 2006 Based on Data From the SEER Database

(2012) Mohamed H. Kamel et al.   JOURNAL OF UROLOGY

Glycosylation changes as important factors for the susceptibility to urinary tract infection: Figure 1

(2011) Joemar Taganna et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer

(2011) C. Mugabe et al.   CLINICAL CANCER RESEARCH

Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells

(2011) Brian G. Coon et al.   INTERNATIONAL JOURNAL OF CANCER

Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder

(2011) Jan Barthelmes et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Lectin Mediated Biorecognition as a Novel Strategy for Targeted Delivery to Bladder Cancer

(2011) Lukas Neutsch et al.   JOURNAL OF UROLOGY

Compensatory endocytosis in bladder umbrella cells occurs through an integrin-regulated and RhoA- and dynamin-dependent pathway

(2010) Puneet Khandelwal et al.   EMBO JOURNAL

Thermosensitive Hydrogels Composed of Hyaluronic Acid and Gelatin as Carriers for the Intravesical Administration of Cisplatin

(2010) Jyh-Ping Chen et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Apical Plasma Membrane Traffic in Superficial Cells of Bladder Urothelium

(2009) Mateja Erdani Kreft et al.   Annals of the New York Academy of Sciences

Endocytotic activity of bladder superficial urothelial cells is inversely related to their differentiation stage

(2009) Mateja Erdani Kreft et al.   DIFFERENTIATION

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery

(2009) Li-Ching Chang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Uroplakins in urothelial biology, function, and disease

(2009) Xue-Ru Wu et al.   KIDNEY INTERNATIONAL

Involvement of Vps33a in the Fusion of Uroplakin-Degrading Multivesicular Bodies with Lysosomes

(2009) Xuemei Guo et al.   TRAFFIC

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY

Role of surfactant on the proteolysis of aqueous bovine serum albumin

(2008) E.M. Rodriguez Porcel et al.   BIOTECHNOLOGY AND BIOENGINEERING

Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells

(2008) Danelle S. Eto et al.   CELLULAR MICROBIOLOGY

Mechanisms and consequences of bladder cell invasion by uropathogenicEscherichia coli

(2008) B. K. Dhakal et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Glycosylation in bladder cancer

(2008) Chikara Ohyama   International Journal of Clinical Oncology

Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors

(2008) Erem Bilensoy et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Intravesical Treatments of Bladder Cancer: Review

(2008) Zancong Shen et al.   PHARMACEUTICAL RESEARCH

Intravesical Pharmacotherapy for Non–Muscle-Invasive Bladder Cancer: A Critical Analysis of Currently Available Drugs, Treatment Schedules, and Long-Term Results

(2007) J. Alfred Witjes et al.   EUROPEAN UROLOGY